These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8703706)
1. Is there any reason to lower proteinuria in a child with nephrotic-range proteinuria who is not clinically edematous? Kees-Folts D Pediatr Nephrol; 1996 Apr; 10(2):180. PubMed ID: 8703706 [No Abstract] [Full Text] [Related]
2. The changing face of childhood nephrotic syndrome. Chesney R Kidney Int; 2004 Sep; 66(3):1294-302. PubMed ID: 15327442 [No Abstract] [Full Text] [Related]
3. ACE inhibition improves glomerular size selectivity in patients with idiopathic membranous nephropathy and persistent nephrotic syndrome. Ruggenenti P; Mosconi L; Vendramin G; Moriggi M; Remuzzi A; Sangalli F; Remuzzi G Am J Kidney Dis; 2000 Mar; 35(3):381-91. PubMed ID: 10692263 [TBL] [Abstract][Full Text] [Related]
4. Proteinuria and albumin homeostasis in the nephrotic syndrome: effect of dietary protein intake. Rodrigo R; Bravo I; Pino M Nutr Rev; 1996 Nov; 54(11 Pt 1):337-47. PubMed ID: 9110562 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibitor does not reduce proteinuria in an infant with congenital nephrotic syndrome of the Finnish type. Birnbacher R; Förster E; Aufricht C Pediatr Nephrol; 1995 Jun; 9(3):400. PubMed ID: 7632545 [No Abstract] [Full Text] [Related]
7. The nephrotic syndrome. Orth SR; Ritz E N Engl J Med; 1998 Apr; 338(17):1202-11. PubMed ID: 9554862 [No Abstract] [Full Text] [Related]
8. Effect of lisinopril on proteinuria in children with nephrotic syndrome in Ilorin, Nigeria. Adedoyin OT; Ologe MO; Anigilaje EA; Adeniyi A Pediatr Nephrol; 2003 Jul; 18(7):727-8. PubMed ID: 12734747 [No Abstract] [Full Text] [Related]
9. Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study. Wilmer WA; Hebert LA; Lewis EJ; Rohde RD; Whittier F; Cattran D; Levey AS; Lewis JB; Spitalewitz S; Blumenthal S; Bain RP Am J Kidney Dis; 1999 Aug; 34(2):308-14. PubMed ID: 10430979 [TBL] [Abstract][Full Text] [Related]
10. Antiproteinuric action of amiloride in paediatric patient with corticoresistant nephrotic syndrome. Liern M; Colazo A; Vallejo G; Zotta E Nefrologia (Engl Ed); 2021; 41(3):304-310. PubMed ID: 36166246 [TBL] [Abstract][Full Text] [Related]
11. Over 11 years of stable renal function after remission of nephrotic-range proteinuria in type I diabetics treated with an ACE inhibitor. McGregor D; Bailey RR Nephron; 1997; 76(3):270-5. PubMed ID: 9226226 [TBL] [Abstract][Full Text] [Related]
12. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria. Praga M; Hernández E; Montoyo C; Andrés A; Ruilope LM; Rodicio JL Am J Kidney Dis; 1992 Sep; 20(3):240-8. PubMed ID: 1519604 [TBL] [Abstract][Full Text] [Related]
13. Hormonal modulation of proteinuria in the nephrotic syndrome. Hutchison FN Am J Nephrol; 1993; 13(5):337-46. PubMed ID: 8116686 [TBL] [Abstract][Full Text] [Related]
14. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy]. Kutyrina IM; Tareeva IE; Shestakova MV; Gerasimenko OI; Zverev KV; Rogov VA; Sheremet'eva OV Ter Arkh; 1994; 66(6):19-22. PubMed ID: 7940357 [TBL] [Abstract][Full Text] [Related]
15. Effectiveness of dietary protein augmentation associated with angiotensin-converting enzyme inhibition in the management of the nephrotic syndrome. Garini G; Mazzi A; Allegri L; Buzio C; Borghetti A Miner Electrolyte Metab; 1996; 22(1-3):123-7. PubMed ID: 8676802 [TBL] [Abstract][Full Text] [Related]